Literature DB >> 27965424

Chemoattractant concentration-dependent tuning of ERK signaling dynamics in migrating neutrophils.

Elizabeth R Zhang1,2, Shanshan Liu1,2, Lani F Wu2,3, Steven J Altschuler2,3, Melanie H Cobb4.   

Abstract

The directed migration (chemotaxis) of neutrophils toward the bacterial peptide N-formyl-Met-Leu-Phe (fMLP) is a crucial process in immune defense against invading bacteria. While navigating through a gradient of increasing concentrations of fMLP, neutrophils and neutrophil-like HL-60 cells switch from exhibiting directional migration at low fMLP concentrations to exhibiting circuitous migration at high fMLP concentrations. The extracellular signal-regulated kinase (ERK) pathway is implicated in balancing this fMLP concentration-dependent switch in migration modes. We investigated the role and regulation of ERK signaling through single-cell analysis of neutrophil migration in response to different fMLP concentrations over time. We found that ERK exhibited gradated, rather than all-or-none, responses to fMLP concentration. Maximal ERK activation occurred in response to about 100 nM fMLP, and ERK inactivation was promoted by p38. Furthermore, we found that directional migration of neutrophils reached a maximal extent at about 100 nM fMLP and that ERK, but not p38, was required for neutrophil migration. Thus, our data suggest that, in chemotactic neutrophils responding to fMLP, ERK displays gradated activation and p38-dependent inhibition and that these ERK dynamics promote neutrophil migration.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27965424      PMCID: PMC5479306          DOI: 10.1126/scisignal.aag0486

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  36 in total

1.  Neutrophil microtubules suppress polarity and enhance directional migration.

Authors:  Jingsong Xu; Fei Wang; Alexandra Van Keymeulen; Maike Rentel; Henry R Bourne
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

2.  Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis.

Authors:  Adelheid Korb; Makiyeh Tohidast-Akrad; Erdal Cetin; Roland Axmann; Josef Smolen; Georg Schett
Journal:  Arthritis Rheum       Date:  2006-09

3.  Extracellular signal-regulated kinases 2 autophosphorylates on a subset of peptides phosphorylated in intact cells in response to insulin and nerve growth factor: analysis by peptide mapping.

Authors:  D J Robbins; M H Cobb
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

4.  Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.

Authors:  Oras Mistafa; Aram Ghalali; Sandeep Kadekar; Johan Högberg; Ulla Stenius
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

Review 5.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

6.  Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.

Authors:  Judith Branger; Bernt van den Blink; Sebastiaan Weijer; Jeffrey Madwed; Carina L Bos; Abhya Gupta; Chan-Loi Yong; Stephen H Polmar; Dariusz P Olszyna; C Erik Hack; Sander J H van Deventer; Maikel P Peppelenbosch; Tom van der Poll
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

7.  Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor.

Authors:  Simon Lea; Chris Harbron; Naimat Khan; George Booth; Jane Armstrong; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

8.  Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases.

Authors:  Xiaowen Liu; Bo Ma; Asrar B Malik; Haiyang Tang; Tao Yang; Bo Sun; Gang Wang; Richard D Minshall; Yan Li; Yong Zhao; Richard D Ye; Jingsong Xu
Journal:  Nat Immunol       Date:  2012-03-25       Impact factor: 25.606

9.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.

Authors:  Christopher Pargellis; Liang Tong; Laurie Churchill; Pier F Cirillo; Thomas Gilmore; Anne G Graham; Peter M Grob; Eugene R Hickey; Neil Moss; Susan Pav; John Regan
Journal:  Nat Struct Biol       Date:  2002-04

10.  Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Stefan Schreiber; Brian Feagan; Geert D'Haens; Jean-Frederic Colombel; Karel Geboes; Mikhail Yurcov; Vasily Isakov; Oleg Golovenko; Charles N Bernstein; Diether Ludwig; Trevor Winter; Ulrich Meier; Chan Yong; Jürgen Steffgen
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382

View more
  10 in total

1.  The trafficking protein JFC1 regulates Rac1-GTP localization at the uropod controlling neutrophil chemotaxis and in vivo migration.

Authors:  Mahalakshmi Ramadass; Jennifer L Johnson; Alex Marki; Jinzhong Zhang; Dennis Wolf; William B Kiosses; Kersi Pestonjamasp; Klaus Ley; Sergio D Catz
Journal:  J Leukoc Biol       Date:  2019-02-12       Impact factor: 4.962

2.  Lipopolysaccharide-Stimulated Human Fetal Membranes Induce Neutrophil Activation and Release of Vital Neutrophil Extracellular Traps.

Authors:  Mancy Tong; Julie A Potter; Gil Mor; Vikki M Abrahams
Journal:  J Immunol       Date:  2019-06-05       Impact factor: 5.422

3.  Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer.

Authors:  Kevin Qian; Simeng Wang; Minnie Fu; Jinfeng Zhou; Jay Prakash Singh; Min-Dian Li; Yunfan Yang; Kaisi Zhang; Jing Wu; Yongzhan Nie; Hai-Bin Ruan; Xiaoyong Yang
Journal:  J Biol Chem       Date:  2018-07-23       Impact factor: 5.157

4.  Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration.

Authors:  Alan Y Hsu; Decheng Wang; Sheng Liu; Justice Lu; Ramizah Syahirah; David A Bennin; Anna Huttenlocher; David M Umulis; Jun Wan; Qing Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

5.  Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands.

Authors:  Shuvasree SenGupta; Lauren E Hein; Yang Xu; Jason Zhang; Jamie R Konwerski; Ye Li; Craig Johnson; Dawen Cai; Janet L Smith; Carole A Parent
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 8.786

6.  Carabin Deficiency Aggravates Hepatic Ischemia-Reperfusion Injury Through Promoting Neutrophil Trafficking via Ras and Calcineurin Signaling.

Authors:  Xuhao Ni; Xiao Wu; Xiao-Xu Zhu; Jian-Hui Li; Xiao-Yu Yin; Ling Lu
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

7.  A chemorepellent inhibits local Ras activation to inhibit pseudopod formation to bias cell movement away from the chemorepellent.

Authors:  Sara A Kirolos; Richard H Gomer
Journal:  Mol Biol Cell       Date:  2021-11-17       Impact factor: 4.138

8.  Method for simultaneous tracking of thousands of unlabeled cells within a transparent 3D matrix.

Authors:  Falk Nette; Ana Cristina Guerra de Souza; Tamás Laskay; Mareike Ohms; Daniel Dömer; Daniel Drömann; Daniel Hans Rapoport
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

Review 9.  Regulation of Neutrophil Functions by Hv1/VSOP Voltage-Gated Proton Channels.

Authors:  Yoshifumi Okochi; Yasushi Okamura
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

10.  Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis.

Authors:  Zihua Hu; Kaiyu Jiang; Mark Barton Frank; Yanmin Chen; James N Jarvis
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.